Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Urinary Bladder Neoplasms 4Colorectal Neoplasms 4Adenocarcinoma Of Esophagus 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Anus Neoplasms 2Tongue Neoplasms 1Stomach Neoplasms 1Salivary Gland Neoplasms 1PRETEXT I Hepatoblastoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Klatskin Tumor 1Hypopharyngeal Neoplasms 1HIV Infections 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Endometrial Neoplasms 1DNA Repair-Deficiency Disorders 1

Interventions

Oxaliplatin 24Fluorouracil 20Capecitabine 16pembrolizumab 15Nivolumab 15Leucovorin 13Trastuzumab 9fludarabine 8Paclitaxel 8Drug Therapy 8Docetaxel 8Cyclophosphamide 8S 1 (combination) 7trastuzumab deruxtecan 6Specimen Handling 6Cisplatin 6Magnetic Resonance Spectroscopy 5Bevacizumab 5zolbetuximab 4Irinotecan 4Biopsy 4zimberelimab 3sintilimab 3fludarabine phosphate 3atezolizumab 3aldesleukin 3XELOX 3Surgical Procedures, Operative 3Ramucirumab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × dehydroftorafur × 90 days × Clear all
NCT03161522 2026-04-15

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡